AHR vs HR Stock Comparison

American Healthcare REIT and Healthcare Realty Trust Prices as of Nov 13, 2026 Peers: Industry group

Head to Head

7 decided of 12

American Healthcare REIT leads on 5 of the 12 questions below (American Healthcare REIT 5, Healthcare Realty Trust 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAHRHRLeader
Larger companyMarket capitalisation $12.61B $6.61B AHR
Cheaper on earningsLower P/E, profitable companies only 131.0x -56.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 91.7x — –
Faster revenue growthRevenue growth, trailing twelve months +21.5% -4.9% AHR
More profitableNet margin, trailing twelve months 3.6% -10.2% AHR
Better return on capitalReturn on invested capital -31.7% — –
Less leveragedLower net debt / EBITDA -0.7x — –
Higher dividend yieldTrailing dividend yield 0.01% 0.05% HR
Better 1-year returnPrice return, last 12 months +19.8% +6.9% AHR
Better 5-year returnAnnualised price return, 5 years — -9.7%/yr –
Less volatileAnnualised volatility, 1 year 26.6% 20.3% HR
Higher overall scoreMean of the five percentile scores vs peers 44/100 38/100 AHR

Percentile Scorecard

AHRHR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAHRHR
Valuation 5 #141 of 149 27 #109 of 149
Growth 86 #22 of 147 32 #100 of 147
Profitability 25 #109 of 144 30 #101 of 144
Financial Health 84 #25 of 149 43 #86 of 149
Shareholder Returns 22 #109 of 139 57 #60 of 139
Overall 44 38
  • AHR ranked among 150 companies in Property REITs
  • HR ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAHRHRSPY
1 month +10.2%+13.4% -2.0%
3 months +6.4%+0.4% -2.8%
6 months +17.1%-4.8% +2.0%
Year to date +22.8%+14.0% +10.6%
1 year +19.8%+6.9% +12.2%
3 years —+31.1% +68.1%
3 years, per year —+9.4% +18.9%
5 years —-39.9% +61.4%
5 years, per year —-9.7% +10.1%
10 years —-30.9% +248.5%
10 years, per year —-3.6% +13.3%

Risk

MeasureAHRHRSPY
Volatility, 1Y 26.6%20.3% 13.6%
Downside volatility, 1Y 27.3%19.8% 13.9%
Beta vs S&P 500, 1Y 0.050.11 1.00
Return / volatility, 1Y 0.740.34 0.90
Max drawdown, 5Y -14.5%-60.6% -25.4%
From 52-week high -2.7%-11.7% -3.2%
52-week high $59.40$21.89 $779.14
52-week low $45.69$16.34 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAHRHR
P/E now vs peer median 130.1xmedian 26.1x -56.2xmedian 26.1x
P/S now vs peer median 5.0xmedian 4.3x 5.7xmedian 4.3x
EV/EBITDA now vs peer median -9.3xmedian 14.5x —median 14.5x
P/FCF now vs peer median -20.2xmedian 21.4x 72.1xmedian 21.4x
P/B now vs peer median 2.4xmedian 1.2x 1.6xmedian 1.2x
PEG now vs peer median 4.02median 1.75 -2.57median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAHRHR
Revenue $2.67B $1.15B
Gross profit $589.22M –
Operating income -$1.92B –
Net income $97.45M -$118.41M
Free cash flow -$662.56M $91.11M
EPS (diluted) $0.44 $-0.34
Cash & equivalents $258.67M $17.50M
Total debt $1.36B $4.25B
Shares (diluted) 217.71M 340.62M
Enterprise value $11.85B $6.52B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAHRHR
P/E 130.1x -56.2x
P/FCF -20.2x 72.1x
P/Operating cash flow 31.8x 18.0x
P/S 5.0x 5.7x
P/B 2.4x 1.6x
P/Tangible book 2.6x 1.8x
EV/EBITDA -9.3x –
EV/EBIT -7.6x –
EV/Revenue 5.4x 9.4x
EV/FCF -21.9x 118.5x
EV/Operating cash flow 34.4x 29.6x
PEG (3Y EPS CAGR) 4.02 -2.57

Growth

14 metrics
MetricAHRHR
Revenue growth (1Y) 21.5% -4.9%
Revenue CAGR (3Y) 16.8% -5.4%
Gross profit growth (1Y) 29.5% –
Gross profit CAGR (3Y) 43.5% –
Operating income growth (1Y) -21.6% –
Operating income CAGR (3Y) -6.8% –
Net income growth (1Y) 255.0% 68.2%
Net income CAGR (3Y) 44.8% 24.6%
EPS growth (1Y) 175.6% 67.3%
EPS CAGR (3Y) 32.4% 21.9%
Operating cash flow growth (1Y) 41.2% –
Operating cash flow CAGR (3Y) 57.9% -11.0%
Free cash flow growth (1Y) -1,027% –
Free cash flow CAGR (3Y) -114.2% -18.9%

Profitability

14 metrics
MetricAHRHR
Gross margin 22.1% –
EBITDA margin -58.3% –
Operating margin -71.8% –
Pretax margin 3.6% –
Net margin 3.6% -10.2%
FCF margin -24.8% 8.0%
Operating cash flow margin 15.8% 31.9%
Return on equity 2.1% -2.8%
Return on assets 1.5% -1.3%
Return on invested capital -31.7% –
Return on capital employed – –
Asset turnover 0.4x 0.1x
Cash conversion (OCF / net income) 4.3x -3.1x
Stock comp / revenue 0.9% 1.5%

Financial Health

11 metrics
MetricAHRHR
Debt / assets 17.9% 47.4%
Debt / equity 0.2x 1.0x
Net debt / EBITDA -0.7x –
Debt / FCF -2.1x 46.6x
Liabilities / assets 26.6% 53.9%
Equity / assets 73.4% 46.1%
Interest coverage -25.6x –
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricAHRHR
Dividend yield 1.7% 5.0%
Net buyback yield -22.2% 3.5%
Shareholder yield -20.5% 8.4%
Payout ratio (earnings) 190.9% -301.7%
Payout ratio (FCF) -28.1% 392.1%
Dividend growth (1Y) 17.0% –
Dividend CAGR (3Y) 35.1% -8.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAHRHR
Forward P/E 91.7xFY2026 –
EPS, next fiscal year $0.63FY2026 $-0.13FY2026
EPS growth, next FY +50.0%FY2026 –
EPS growth, the year after +36.5% –
Revenue, next fiscal year $2.65BFY2026 $1.17BFY2026
Revenue growth, next FY +17.1%FY2026 -0.7%FY2026
Revenue growth, the year after +29.9% -8.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAHRHR
Held by institutions 100.0% 100.0%
Institutions holding 573 460
Change in shares held, QoQ +19.9% +0.8%
Institutions buying 335 226
Institutions selling 165 146
Buyers to sellers 2.03 1.55

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AHRHR
AHR 1.00 0.46
HR 0.46 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, AHR and HR?

American Healthcare REIT (AHR) is the largest by market capitalisation: American Healthcare REIT (AHR) $12.61B, Healthcare Realty Trust (HR) $6.61B.

Which company is growing faster?

American Healthcare REIT (AHR) grew revenue fastest over the trailing twelve months: American Healthcare REIT (AHR) +21.5%, Healthcare Realty Trust (HR) -4.9%.

Which company is more profitable?

American Healthcare REIT (AHR) has the highest net margin (American Healthcare REIT (AHR) 3.6%, Healthcare Realty Trust (HR) -10.2%).

Which stock has performed better?

Over the past year American Healthcare REIT (AHR) returned the most: American Healthcare REIT (AHR) +19.8%, Healthcare Realty Trust (HR) +6.9%. Returns are price only, before dividends.

Which pays a higher dividend?

Healthcare Realty Trust (HR) has the highest dividend yield: American Healthcare REIT (AHR) 0.01%, Healthcare Realty Trust (HR) 0.05%.

Which stock is riskier?

By one-year price volatility, Healthcare Realty Trust (HR) has been the steadiest (American Healthcare REIT (AHR) 26.6%, Healthcare Realty Trust (HR) 20.3%). Volatility measures how widely the price swings, not the risk of the business.

Do AHR and HR move together?

Their daily returns over the past year have a correlation of 0.46, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, AHR and HR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, American Healthcare REIT (AHR) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.